Theoretical insights into the effect of halogenated substituent on the electronic structure and spectroscopic properties of the favipiravir tautomeric forms and its implications for the treatment of COVID-19
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18450%2F21%3A50018550" target="_blank" >RIV/62690094:18450/21:50018550 - isvavai.cz</a>
Alternative codes found
RIV/62690094:18470/21:50018550
Result on the web
<a href="https://pubs.rsc.org/en/content/articlelanding/2021/RA/D1RA06309J" target="_blank" >https://pubs.rsc.org/en/content/articlelanding/2021/RA/D1RA06309J</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1039/d1ra06309j" target="_blank" >10.1039/d1ra06309j</a>
Alternative languages
Result language
angličtina
Original language name
Theoretical insights into the effect of halogenated substituent on the electronic structure and spectroscopic properties of the favipiravir tautomeric forms and its implications for the treatment of COVID-19
Original language description
In this study, we systematically investigated the electronic structure, spectroscopic (nuclear magnetic resonance, infrared, Raman, electron ionization mass spectrometry, UV-Vis, circular dichroism, and emission) properties, and tautomerism of halogenated favipiravir compounds (fluorine, chlorine, and bromine) from a computational perspective. Additionally, the effects of hydration on the proton transfer mechanism of the tautomeric forms of the halogenated favipiravir compounds are discussed. Our results suggest that spectroscopic properties allow for the elucidation of such tautomeric forms. As is well-known, the favipiravir compound has excellent antiviral properties and hence was recently tested for the treatment of new coronavirus (SARS-CoV-2). Through in silico modeling, in the current study, we evaluate the role of such tautomeric forms in order to consider the effect of drug-metabolism in the inhibition process of the main protease (M-pro) and RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 virus. According to the molecular docking, all halogenated compounds presented a better interaction energy than the co-crystallized active ligand (-3.5 kcal mol(-1)) in the viral RdRp, in both wild-type (-6.3 to -6.5 kcal mol(-1)) and variant (-5.4 to -5.6 kcal mol(-1)) models. The variant analyzed for RdRp (Y176C) decreases the affinity of the keto form of the compounds in the active site, and prevented the ligands from interacting with RNA. These findings clearly indicated that all these compounds are promising as drug candidates for this molecular target.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10406 - Analytical chemistry
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
RSC ADVANCES
ISSN
2046-2069
e-ISSN
—
Volume of the periodical
11
Issue of the periodical within the volume
56
Country of publishing house
GB - UNITED KINGDOM
Number of pages
17
Pages from-to
35228-35244
UT code for WoS article
000713408900001
EID of the result in the Scopus database
2-s2.0-85119854240